BioRunUp - Riding the Waves of BioTech

EXAS Gaining Momentum

BioRunUp — Wed, 08 Sep 2010 04:57:14 +0000

Take a look at the EXAS chart from 8/19 – 9/7. A clear upward trend is easily seen. Currently I am holding both long shares and $5 October Calls. The November Calls are not yet available and I will be interested in take a position at that time. Watch for EXAS to break the $5 [...]

An Interesting Week Ahead for QCOR

BioRunUp — Tue, 07 Sep 2010 03:30:38 +0000

Just after we posted an article entitled “QCOR Gaining Momentum Before its 9/11/10 PDUFA Date” on August 30th, QCOR took a turn for the worse. In a strangely timed departure, the company announced the resignation their Chief Medical Officer, Dr. Jason Zielonka effective 9/15/10. The uncertainty caused by this resignation has dragged the stock down from $10.88 [...]

This Week’s Watchlist 9/6/10

BioRunUp — Sun, 05 Sep 2010 13:55:13 +0000

QCOR – Obviously top of the watchlist this week is Questcor. This stock has been stuck in a holding pattern since announcing the resignation of their Chief Medical Officer on August 30th. If there will be any activity on this stock expect it to be soon. The official PDUFA falls on Saturday (9/11), which usually [...]

Another Great Free Resource – SECFilings.com

BioRunUp — Thu, 02 Sep 2010 17:15:20 +0000

We stumbled across this free service and we wanted to pass it along to our subscribers. Once you create a free account at SECfilings.com they email you instant updates when one of the companies you follow registers a new document with the SEC. This will include all major news items, insider buying/ selling, and quarterly reports. Having [...]

BIOD Run-Up Target

BioRunUp — Wed, 01 Sep 2010 13:30:40 +0000

This amazing research and information was posted in the BioRunUp forums. We feel that it deserves its own post on BioRunUp. Feel free to double check the numbers as well as the research. There is a thread on this subject in the forums ( LINK ), so please post your thoughts there. A big ‘Thank You’ [...]

CADX – 11/04/10 PDUFA for IV Acetaminophen

BioRunUp — Tue, 31 Aug 2010 15:02:12 +0000

Tucked just past the madness of the October FDA plays is Cadence Pharmaceuticals (CADX). It has an early November PDUFA date and expected FDA decision for OFIRMEV (intravenous or IV acetaminophen). Let’s take a closer look at OFIRMEV and Cadence Pharmaceuticals. Summary Recent Events CADX had an FDA PDUFA Priority Review date of 11/13/09 for OFIRMEV. The [...]

QCOR Gaining Momentum Before its 9/11/10 PDUFA Date

BioRunUp — Mon, 30 Aug 2010 13:00:15 +0000

QCOR is quickly gaining momentum as it approaches its PDUFA date of 9/11/10 of Acthar for the treatment of infantile spasms. Over the last week its shares have picked up momentum in its final runup, climbing from a low of $9.56 on Tuesday 8/24 to its high of $10.85 on Friday. This represents a gain [...]

This Week’s Watchlist 8/30/10

BioRunUp — Sun, 29 Aug 2010 14:00:42 +0000

QCOR - On Friday QCOR reached a high of $10.86, taking advantage of the market upswing. It’s PDUFA date is 9/11/10 so I would expect the run-up to really begin to kick in this week. Approval is generally expected, which may cause the price to run-up into the $12 range. However this may limit the [...]

FDA Calendar Updates 8/27/10

BioRunUp — Fri, 27 Aug 2010 09:25:28 +0000

Only two updates this week… CPIX - PDUFA date moved back 3 months to 12/10/10 LCI - NDA for morphine sulfate products 12/26/10

BIOD- Time to Load Up or Time to Sell?

BioRunUp — Wed, 25 Aug 2010 12:01:14 +0000

Biodel has a PDUFA date of 10/30/10 for its diabetes drug VIAject. Biodel is taking advantage of what the FDA calls a “505(b)(2)” application. This route permits companies to obtain FDA approval of new drug applications (NDAs) by relying, in part, on the agency’s findings for a previously approved drug. (For more information on Biodel see our [...]